 Naloxone
"Naloxone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
| Descriptor ID |
D009270
|
| MeSH Number(s) |
D03.132.577.249.706 D03.549.686.750 D03.605.497.750 D04.615.723.795.706
|
| Concept/Terms |
Nalone- Nalone
- SERB Brand of Naloxone Hydrochloride
Naloxon Curamed- Naloxon Curamed
- Curamed, Naloxon
- Curamed Brand of Naloxone Hydrochloride
Naloxon-ratiopharm- Naloxon-ratiopharm
- Naloxon ratiopharm
- Naloxonratiopharm
- ratiopharm Brand of Naloxone Hydrochloride
Narcan- Narcan
- United Drug Brand of Naloxone Hydrochloride
- Lamepro Brand of Naloxone Hydrochloride
- Bristol-Myers Squibb Brand of Naloxone Hydrochloride
- Bristol Myers Squibb Brand of Naloxone Hydrochloride
- Endo Brand of Naloxone Hydrochloride
- Narcanti
- Boots Brand of Naloxone Hydrochloride
MRZ-2593- MRZ-2593
- MRZ 2593
- MRZ2593
- MRZ 2593-Br
- MRZ 2593 Br
- MRZ 2593Br
Naloxone Abello- Naloxone Abello
- Abello, Naloxone
- Abello Brand of Naloxone Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Naloxone".
Below are MeSH descriptors whose meaning is more specific than "Naloxone".
This graph shows the total number of publications written about "Naloxone" by people in UAMS Profiles by year, and whether "Naloxone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 2 | 1 | 3 | | 2023 | 0 | 1 | 1 | | 2022 | 0 | 3 | 3 | | 2020 | 1 | 0 | 1 | | 2016 | 0 | 2 | 2 | | 2015 | 0 | 1 | 1 | | 2013 | 4 | 2 | 6 | | 2012 | 1 | 1 | 2 | | 2011 | 3 | 0 | 3 | | 2010 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2004 | 1 | 0 | 1 | | 2003 | 1 | 1 | 2 | | 2002 | 1 | 1 | 2 | | 1999 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 1996 | 1 | 1 | 2 | | 1995 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 | | 1993 | 1 | 1 | 2 | | 1991 | 2 | 0 | 2 | | 1990 | 2 | 2 | 4 | | 1989 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Naloxone" by people in Profiles over the past ten years.
-
Hiranita T, Flynn SM, Grisham AK, Mijares AE, Murphy EN, France CP. Gabapentinoids Increase the Potency of Fentanyl and Heroin and Decrease the Potency of Naloxone to Antagonize Fentanyl and Heroin in Rats Discriminating Fentanyl. J Pharmacol Exp Ther. 2024 Oct 18; 391(2):317-334.
-
Jones CM, Shoff C, Blanco C, Losby JL, Ling SM, Compton WM. Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose. JAMA Intern Med. 2024 Aug 01; 184(8):954-962.
-
Tackett WR, Yalakala J, Hambuchen MD. Co-administration of naloxone and dexmedetomidine to simultaneously reverse acute effects of fentanyl and methamphetamine in rats. Drug Alcohol Depend. 2024 Jun 01; 259:111301.
-
Hiranita T, Ho NP, France CP. Ventilatory Effects of Fentanyl, Heroin, and d-Methamphetamine, Alone and in Mixtures in Male Rats Breathing Normal Air?. J Pharmacol Exp Ther. 2024 01 17; 388(2):244-256.
-
Riley E, Trotter S, Dayer L, Teigen A, Nagel C, Stickley K, LaBorde P, Richardson L, McFerguson R, Ward N, Anders M. Interprofessional Naloxone Student Training to Manage Suspected Opioid Overdose. Clin Nurse Spec. 2023 Jan-Feb 01; 37(1):26-35.
-
Costantino RC, Tilley LC, Gressler LE, Zarzabal LA, Vasquez CM, Peters S, Pakieser J, Highland KB, dosReis S. Naloxone Prescribing Associated With Reduced Emergency Department Visits in the Military Health System. Med Care. 2022 12 01; 60(12):901-909.
-
Hohmann LA, Fox BI, Garza KB, Wang CH, Correia C, Curran GM, Westrick SC. Impact of a Multicomponent Educational Intervention on Community Pharmacy-Based Naloxone Services Implementation: A Pragmatic Randomized Controlled Trial. Ann Pharmacother. 2023 06; 57(6):677-695.
-
Stephens RJ, Filip AB, Baumgartner KT, Schwarz ES, Liss DB. Benzonatate Overdose Presenting as Cardiac Arrest with Rapidly Narrowing QRS Interval. J Med Toxicol. 2022 10; 18(4):344-349.
-
Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value Health. 2020 04; 23(4):451-460.
-
Tanda G, Mereu M, Hiranita T, Quarterman JC, Coggiano M, Katz JL. Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids. Neuropsychopharmacology. 2016 10; 41(11):2772-81.
-
Saucier CD, Zaller N, Macmadu A, Green TC. An Initial evaluation of law enforcement overdose training in Rhode Island. Drug Alcohol Depend. 2016 May 01; 162:211-8.
-
Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T, Cochran TA, Pomrenze MB, Galer EL, Kopajtic TA, Li CM, Amat J, Larson G, Cooper DC, Huang Y, O'Neill CE, Yin H, Zahniser NR, Katz JL, Rice KC, Maier SF, Bachtell RK, Watkins LR. DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. Mol Psychiatry. 2015 Dec; 20(12):1525-37.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|